Latham & Watkins advises Alpha II and existing shareholder WestView Capital Partners on TA Associates strategic Growth investment. TA Associates, a leading global private equity firm,...
TA Associates Strategic Growth Investment in Alpha II
U.S. Physical Therapy’s $150 Million Common Stock Offering
Latham & Watkins advises the underwriters on US$150 million offering by U.S. Physical Therapy. U.S. Physical Therapy, Inc. has announced that it has priced an underwritten...
Phathom Pharmaceuticals’ $130 Million Public Offering of Common Stock
Latham & Watkins advises Phathom Pharmaceuticals in pricing of US$130 million public offering of common stock. Phathom Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and...
Ecovyst’s Secondary Offering of Common Stock Shares
Latham & Watkins advised the underwriters on Ecovyst’s secondary offering of 14,000,000 shares of common stock by a selling stockholder and repurchase of common stock. Ecovyst...
NextRoll’s $50 Million Financing Deal From Capital IP
Latham & Watkins advises NextRoll in US$50 million financing deal from Capital IP. NextRoll, the San Francisco-based marketing technology company delivering products for ambitious marketers to...
Credito Emiliano – Credem’s €400 Million Green Bond
In the operation, Allen & Overy assisted Credito Emiliano – Credem, while Clifford Chance supported the pool of banks. Credito Emiliano – Credem has completed the...
The Vita Coco Company’s Common Stock Secondary Offering
Latham & Watkins represents The Vita Coco Company, Inc. in upsized secondary offering of common stock by selling stockholder. The Vita Coco Company, Inc., a leading...
US Foods Holding Corp’s Secondary Public Offering of Common Stock
Latham & Watkins’ capital markets team represents the underwriter in the offering by the leading foodservice distributor. US Foods Holding Corp. has announced the pricing of a...
Guardant Health’s Upsized Public Offering of Common Stock
Latham & Watkins Advises Guardant Health in Pricing of Upsized Public Offering of Common Stock. Guardant Health, Inc., a leading precision oncology company, has announced the pricing...
Linklaters Continues U.S. Expansion with Arrival of Market-Leading Litigation Partner Robin Nunn
Linklaters announced that Robin Nunn has joined the firm’s New York and Washington, DC offices as a partner in the Litigation, Arbitration, and Investigations practice. Robin’s...
L’Oréal’s €2 Billion EMTN Programme
Clifford Chance has advised L’Oréal on its EMTN programme establishment and on its first drawdown issuance under this EMTN programme for an aggregate nominal amount of...
Permira’s Acquisition of Florence Group
In the transaction, the Permira funds were assisted by Legance, Latham & Watkins, Clifford Chance and Maisto e Associati; Gruppo Florence sellers are supported by GOP,...